Evidence map›Paper›PMID 38353470›Full record

ReviewJournal of cellular and molecular medicine2024

Targeting type H vessels in bone-related diseases.

Juan Xu, Shuang-Jian He, Ting-Ting Xia, Yu Shan, Liang Wang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of the Total Flavonoids fromCurrent molecular medicine · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. The Interplay of Angiogenesis and Osteogenesis in Non-Stabilized Incomplete Tibial Fractures: A Temporal Study in Rats.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Targeting type H vessels in bone-related diseases.Journal of cellular and molecular medicine · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Juan XuOutpatient Department, Children's Hospital of Soochow University, Suzhou, China.
Shuang-Jian HeDepartment of Orthopaedics, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.
Ting-Ting XiaClinical Research Institute, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.
Yu ShanDepartment of Orthopeadics, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Liang WangDepartment of Orthopaedics, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.ORCID 0000-0003-2476-063X
Soochow University · CNSuzhou Municipal Hospital · CN

Funding

Medical Research Project of Jiangsu Commission of Health Z2021043National Nature Science Foundation of China 81773439New Clinical Diagnosis and Treatment Technology and Public Health Project of Suzhou SKY2022036Project of the Science and Education Promoting Health in Wujiang District of Suzhou City wwk201805
6 · The paper itself

Abstract

Blood vessels are essential for bone development and metabolism. Type H vessels in bone, named after their high expression of CD31 and Endomucin (Emcn), have recently been reported to locate mainly in the metaphysis, exhibit different molecular properties and couple osteogenesis and angiogenesis. A strong correlation between type H vessels and bone metabolism is now well-recognized. The crosstalk between type H vessels and osteoprogenitor cells is also involved in bone metabolism-related diseases such as osteoporosis, osteoarthritis, fracture healing and bone defects. Targeting the type H vessel formation may become a new approach for managing a variety of bone diseases. This review highlighted the roles of type H vessels in bone-related diseases and summarized the research attempts to develop targeted intervention, which will help us gain a better understanding of their potential value in clinical application.

Indexed as

Bone Diseases, MetabolicOsteoporosisBone and BonesFracture HealingHumansNeovascularization, PhysiologicOsteogenesisangiogenesisosteoarthritisosteogenesisosteoporosistype H vessels

Identifiers

PMID38353470
PMCPMC10865918
OpenAlexW4391812675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.